Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours Β· Estimated delivery Aug 16 - Aug 21
This property makes it particularly attractive for calorie-conscious individuals
Despite these pharmacokinetic differences, both formulations work through the same mechanism of action once absorbed
Tirzepatide (Mounjaro, Zepbound) es un agonista dual del receptor de GIP/GLP-1 aprobado por la FDA para el tratamiento de la diabetes tipo 2 y para el control del peso en adultos con obesidad (IMC 30 kg/m) o sobrepeso (IMC 27 kg/m) con al menos una comorbilidad relacionada con el peso, como complemento a una dieta reducida en caloras y mayor actividad fsica
Bruner-Tran KL, Herington JL et al
Acknowledgements This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License ( which permits any non-commercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made
US$ 26.53
US$ 24.84
US$ 28.37
US$ 26.40
US$ 29.02
US$ 23.30
US$ 27.76
US$ 24.88
US$ 21.23
US$ 26.59
